Company / Financials
BIOREGENX, INC. Financials
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.9M
FY2025 · -20.8% YoY
Net Income
-$1.5M
FY2025 · +93.3% YoY
Profit Margin
-83.2%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$411.0K
FY2025
Total Debt
$1.2M
-0.26x debt/equity
Equity
-$4.5M
FY2025
ROA
-375.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -88.43 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.9M-20.8% YoYNet Income HistoryProfit after all expenses and taxes-$1.5M+93.3% YoYGross Profit HistoryRevenue minus cost of goods sold$1.5M-9.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$350.9K-48.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$1.2M+94.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$2.0M-65.7% YoYR&D Expense HistoryResearch and development spending$31.8KInterest Expense HistoryCost of borrowing and debt obligations$299.6K+3.1% YoYIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$0.03-200.0% YoY